IL118833A - Sertraline for use as a medicament in the treatment of post-myocardial infarction patients - Google Patents

Sertraline for use as a medicament in the treatment of post-myocardial infarction patients

Info

Publication number
IL118833A
IL118833A IL11883396A IL11883396A IL118833A IL 118833 A IL118833 A IL 118833A IL 11883396 A IL11883396 A IL 11883396A IL 11883396 A IL11883396 A IL 11883396A IL 118833 A IL118833 A IL 118833A
Authority
IL
Israel
Prior art keywords
sertraline
myocardial infarction
medicament
post
treatment
Prior art date
Application number
IL11883396A
Other languages
English (en)
Other versions
IL118833A0 (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL118833A0 publication Critical patent/IL118833A0/xx
Publication of IL118833A publication Critical patent/IL118833A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL11883396A 1995-07-17 1996-07-11 Sertraline for use as a medicament in the treatment of post-myocardial infarction patients IL118833A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US143795P 1995-07-17 1995-07-17

Publications (2)

Publication Number Publication Date
IL118833A0 IL118833A0 (en) 1996-10-31
IL118833A true IL118833A (en) 2000-07-26

Family

ID=21696010

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11883396A IL118833A (en) 1995-07-17 1996-07-11 Sertraline for use as a medicament in the treatment of post-myocardial infarction patients

Country Status (15)

Country Link
EP (1) EP0768083B1 (da)
JP (1) JPH0930959A (da)
KR (1) KR970005283A (da)
CN (1) CN1147937A (da)
AT (1) ATE235237T1 (da)
AU (1) AU721967B2 (da)
CA (1) CA2181225C (da)
DE (1) DE69626916T2 (da)
DK (1) DK0768083T3 (da)
ES (1) ES2192217T3 (da)
IL (1) IL118833A (da)
MY (1) MY117638A (da)
NZ (1) NZ299006A (da)
PT (1) PT768083E (da)
ZA (1) ZA966027B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0980241B1 (en) * 1997-07-01 2003-12-17 Pfizer Products Inc. Gelatine encapsulated solution dosage forms of sertraline
CA2290966C (en) 1997-07-01 2005-12-20 Pfizer Inc. Sertraline salts and sustained-release dosage forms of sertraline
GB9714841D0 (en) * 1997-07-14 1997-09-17 Smithkline Beecham Plc Treatment method
ES2209490T3 (es) * 1998-10-13 2004-06-16 Pfizer Products Inc. Concentrado oral de sertralina.
US6727283B2 (en) * 1998-10-13 2004-04-27 Pfizer Inc. Sertraline oral concentrate
US6245782B1 (en) 1999-05-17 2001-06-12 Heartdrug Research L.L.C. Methods of inhibiting platelet activation with selective serotonin reuptake inhibitors
GB0814466D0 (en) * 2008-08-07 2008-09-10 Rosemont Pharmaceuticals Ltd Sertraline composition
JP2022532637A (ja) * 2019-05-15 2022-07-15 バステラ カンパニー リミテッド オートファジー活性化剤を有効成分として含む心脳血管疾患の予防または治療用組成物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5114976A (en) * 1989-01-06 1992-05-19 Norden Michael J Method for treating certain psychiatric disorders and certain psychiatric symptoms

Also Published As

Publication number Publication date
AU6053496A (en) 1997-01-23
PT768083E (pt) 2003-08-29
DE69626916D1 (de) 2003-04-30
DE69626916T2 (de) 2003-10-09
MY117638A (en) 2004-07-31
DK0768083T3 (da) 2003-06-23
CA2181225C (en) 1999-03-23
EP0768083A2 (en) 1997-04-16
JPH0930959A (ja) 1997-02-04
EP0768083A3 (en) 1999-12-01
EP0768083B1 (en) 2003-03-26
ES2192217T3 (es) 2003-10-01
AU721967B2 (en) 2000-07-20
IL118833A0 (en) 1996-10-31
NZ299006A (en) 2000-08-25
ZA966027B (en) 1998-01-16
CN1147937A (zh) 1997-04-23
CA2181225A1 (en) 1997-01-18
KR970005283A (ko) 1997-02-19
ATE235237T1 (de) 2003-04-15

Similar Documents

Publication Publication Date Title
AU609664B1 (en) A method of treating premature ejaculation using sertraline
KR960702318A (ko) 근육 질병 및 장애의 치료방법
DE60216830D1 (de) Pharmazeutische Zusammensetzungen zur Behandlung von Störungen des ZNS oder anderen Erkrankungen
AU2002225772A1 (en) Therapeutic agents and methods of use thereof for treating an amyloidogenic disease
CA2427227A1 (en) Lactam compound
MY106075A (en) A method of treating anxiety-related disorders using sertraline.
MX9603489A (es) Peptidos opiodes novedosos para el tratamiento del dolor y uso de los mismos.
DE69521536D1 (de) Zusammensetzungen die G-CSF und ein TNF-Bindungsprotein enthalten
IL118833A (en) Sertraline for use as a medicament in the treatment of post-myocardial infarction patients
CA2167257A1 (en) Use of Sertraline to Treat Cancer Patients
NZ268110A (en) Use of ropivacaine salt in pharmaceutical compositions for the treatment of pain with sensoric block and minimal motor blockage
NZ303993A (en) Pharmaceutical compositions containing aminotetralin derivatives for treating cardiac disorders
HU905683D0 (en) The treatment of drug dependence by using sertraline
CA2135752A1 (en) Use of (E)-2-(p-Fluorophenethyl)-3-Fluoroallylamine in the Treatment of Alzheimer's Disease
MX9602793A (es) Uso de sertralina para tratar pacientes despues de un infarto de miocardio.
MX9701528A (es) Derivados de 1, 1, 2,- trifenilbut-1-eno para tratar la enfermedad de alzheimer.
MX9801192A (es) Nuevos peptidos opioides.
ITMI910442V0 (it) Struttura di zoccolo ortopedico, o simile, in particolare per la prevenzione o la cura del valgismo dell'alluce

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees